Doyne Honeycomb Retinal Dystrophy Latest Advances

Find the Latest Research About Doyne Honeycomb Retinal Dystrophy

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Clinical Surrogate Endpoints in Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Findings From a Two-Year Natural History Study.

Clinical Surrogate Endpoints in Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Findings From a Two-Year Natural History Study.

Journal: Investigative ophthalmology & visual science

Published: September 14, 2026

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1.

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1.

Journal: JAMA ophthalmology

Published: September 10, 2026

The First Case Series of Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy in Türkiye Identified with EFEMP1 Gene Mutation.

The First Case Series of Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy in Türkiye Identified with EFEMP1 Gene Mutation.

Journal: Turkish journal of ophthalmology

Published: August 26, 2026

The eye of a beehive: Doyne honeycomb retinal dystrophy.

The eye of a beehive: Doyne honeycomb retinal dystrophy.

Journal: Eye (London, England)

Published: July 06, 2026

Drusenoid macular dystrophies in Singaporean Chinese: first report of Doyne honeycomb retinal dystrophy and late-onset retinal degeneration from Southeast Asia.

Drusenoid macular dystrophies in Singaporean Chinese: first report of Doyne honeycomb retinal dystrophy and late-onset retinal degeneration from Southeast Asia.

Journal: Ophthalmic genetics

Published: March 16, 2026

Interactions Between Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 and Tissue Inhibitor of Metalloproteinases-3 and Relevance to Age-Related Macular Degeneration.

Interactions Between Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 and Tissue Inhibitor of Metalloproteinases-3 and Relevance to Age-Related Macular Degeneration.

Journal: Ophthalmology science

Published: February 11, 2026

Antisense oligonucleotide allele-specific targeting of EFEMP1 in a patient-derived model of Doyne honeycomb retinal dystrophy.

Antisense oligonucleotide allele-specific targeting of EFEMP1 in a patient-derived model of Doyne honeycomb retinal dystrophy.

Journal: Molecular therapy. Nucleic acids

Published: August 15, 2025

Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese, Autosomal Dominant Drusen).

Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese, Autosomal Dominant Drusen).

Journal: Advances in experimental medicine and biology

Published: July 30, 2025

Early-onset drusen in Malattia Leventinese with EFEMP1 mutation differ from drusen in age-related macular degeneration.

Early-onset drusen in Malattia Leventinese with EFEMP1 mutation differ from drusen in age-related macular degeneration.

Journal: Romanian journal of ophthalmology

Published: May 27, 2025

Restoration of impaired lysosomal function mitigates drusen-like deposit formation and cell death in Malattia Leventinese.

Restoration of impaired lysosomal function mitigates drusen-like deposit formation and cell death in Malattia Leventinese.

Journal: JCI insight

Published: April 11, 2025

DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESE.

DRUSEN VOLUME AS CLINICAL OUTCOME MEASURE IN SUBJECTS WITH MALATTIA LEVENTINESE.

Journal: Retina (Philadelphia, Pa.)

Published: January 22, 2025

A New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant.

A New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant.

Journal: American journal of medical genetics. Part A

Published: June 25, 2024

Showing 1-12 of 60

Last Updated: 11/08/2026